ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,038, issued on Oct. 6, was assigned to SterileCare Inc. (Markham, Calif.).
"Synergistic activity of novel compounds against planktonic and biofilm cells of clinically relevant pathogens" was invented by Karen Mueller (Newmarket, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions, methods of preparing, and method of use of a composition comprising: (a) about 0.05 wt % to about 10.0 wt % ethylenediamaminetetraacetic acid, a salt thereof, a chelating agent, or a combination thereof; (b) from about 2.0 wt % to 50.0 wt % ethanol (ET), isopropyl alcohol (IPA), or a combination thereof; and (c) from about 0.01...